Seonglae Chowww.nejm.org
https://www.nejm.org/doi/full/10.1056/NEJMoa2301972
Michael Weintraub on Twitter
NEW Data drop at #ADA2023: Retatrutide, a triple agonist (GLP1, GIP, glucagon) lost an incredible 24.2% of their body weight, which amounts to 58 lbs! This data suggests retatrutide is the most effective anti-obesity med to date and approaches bariatric surgery outcomes. pic.twitter.com/rAecoE3d0t— Michael Weintraub (@MWeintraubMD) June 26, 2023
https://twitter.com/MWeintraubMD/status/1673435733497978888
twitter.com
https://twitter.com/DanielJDrucker/status/1673383917888348174
Most powerful obesity drug yet: People lost up to 25% of weight in trial
Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.
https://arstechnica.com/health/2026/09/most-powerful-obesity-drug-yet-people-lost-up-to-25-of-weight-in-trial/
